Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.

Song J, Yang P, Chen C, Ding W, Tillement O, Bai H, Zhang S

Open source

DOI
10.1038/s41392-025-02266-z
Published
2025 Jul 18
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-025-02266-z,
  title = {Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.},
  author = {Song J and Yang P and Chen C and Ding W and Tillement O and Bai H and Zhang S},
  year = {2025},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-025-02266-z},
  url = {https://doi.org/10.1038/s41392-025-02266-z}
}

RIS

TY  - JOUR
TI  - Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.
AU  - Song J
AU  - Yang P
AU  - Chen C
AU  - Ding W
AU  - Tillement O
AU  - Bai H
AU  - Zhang S
PY  - 2025
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-025-02266-z
UR  - https://doi.org/10.1038/s41392-025-02266-z
ER  -

APA

J, S., P, Y., C, C., W, D., O, T., H, B., & S, Z. (2025). Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-025-02266-z

Source records